Alnajashi, Hind. “Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment”. Journal of Contemporary Medical Sciences, vol. 11, no. 4, Aug. 2025, doi:10.22317/jcms.v11i4.1916.